Engage in exclusive presentations from your peers and ophthalmic industry leaders about re-energizing glaucoma practice while overcoming COVID-19. Participate in two conference tracks: Advancing Technology for Glaucoma management and Optimizing Glaucoma Practice. Ask questions and participate in live chat alongside your peers.
Learn more about ZEISS broad portfolio including innovations in diagnostic equipment for glaucoma and beyond.
Chat live with ZEISS representatives throughout the event. Ask questions, gather information, book a demo, or just say hello.
Access exclusive on-demand education with credible scientific and clinical content presented by today’s top key opinion leaders.
Live streaming has ended, but you can re-watch all of the live education sessions below.
The glaucoma department at Hospital Clínic of Barcelona deferred almost 1,000 glaucoma outpatient attendances over the course of COVID-19 lockdown. During the confinement, careful review of patient records and directed telephone anamnesis were made to assess risk stratification. Phased attention was scheduled into three different periods of time. Integrated clinical, structural, and functional data obtained in a remote decision setting was used to adapt the glaucoma practice to post COVID-19 challenges.
Outcomes of two clinical studies are presented: A) Viscocanaloplasty in high myopic eye with analysis of IOP reduction, postoperative hypotensive medication and incidence of complications B) Comparison of SITA Faster with SITA Standard and SITA Fast strategies to determine preferred visual field test used during COVID-19 pandemic
Ike Ahmed, MD and his team at the Prism Eye Institute have actively been supporting their peers during these challenging times through interactive broadcasts and webinars. Dr. Ahmed will provide an overview of OCT utilization in his practice and how best to prioritize OCT usage post COVID-19, when your backlog of patients are allowed to return to the practice for in-person consultations/exams.
Retrospective view on glaucoma management from 1997 till today. Various approaches to diagnosing and managing glaucoma patients were developed during different phases of the practice. Clinical cases where technology made a difference will be presented.
The 24-2C pattern frequently shows damage in the paracentral area that has not been detected or was underestimated using the 24-2 or 30-2 pattern. In order to confirm such findings, sometimes patients are reexamined soon after this “initial” determination of paracentral losses. But there are also patients that show defects on the RNFL analysis which are not reflected in the 24-2C and indicate that more peripheral areas are affected.
A quick look at research and technological advancements in eye care provided by ZEISS's top scientists, clinicians and engineers. These select posters include the leading edge innovations using SITA Faster 24-2C, CLARUS® Ultra-widefield imaging, and CIRRUS® OCT.
The analysis of the relationship between structure and function in glaucoma is necessary to understand both the severity and the progression of the disease. The structure-function agreement of the eyes in different stages of glaucoma was evaluated based on the 6 structure-function zones of the Garway-Heath map and by categorizing the cases into stages according to the Glaucoma Staging System (GSS).